Andrew I. Schafer
#136,292
Most Influential Person Now
Andrew I. Schafer's AcademicInfluence.com Rankings
Andrew I. Schaferphilosophy Degrees
Philosophy
#6893
World Rank
#10011
Historical Rank
Logic
#3986
World Rank
#5225
Historical Rank

Download Badge
Philosophy
Andrew I. Schafer's Degrees
- Doctorate Medicine University of California, San Francisco
- PhD Biochemistry University of California, San Francisco
Why Is Andrew I. Schafer Influential?
(Suggest an Edit or Addition)Andrew I. Schafer's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. (1987) (954)
- Platelets and shear stress. (1996) (940)
- Bleeding and thrombosis in the myeloproliferative disorders. (1984) (433)
- Biochemical mechanisms of platelet activation. (1989) (387)
- Effects of Nonsteroidal Antiinflammatory Drugs on Platelet Function and Systemic Hemostasis (1995) (338)
- The hypercoagulable states. (1985) (331)
- Nitric oxide induces heme oxygenase-1 gene expression and carbon monoxide production in vascular smooth muscle cells. (1997) (321)
- Morning increase in platelet aggregability. Association with assumption of the upright posture. (1988) (317)
- Clinical consequences of acquired transfusional iron overload in adults. (1981) (292)
- von Willebrand factor binding to platelet GpIb initiates signals for platelet activation. (1991) (288)
- Thrombosis and Hemorrhage (2002) (275)
- Vascular smooth muscle cell heme oxygenases generate guanylyl cyclase-stimulatory carbon monoxide. (1995) (243)
- Goldman-Cecil Medicine (2015) (223)
- Leukotriene B4 stimulates polymorphonuclear leukocyte adhesion to cultured vascular endothelial cells. (1984) (218)
- Hemodynamic forces induce the expression of heme oxygenase in cultured vascular smooth muscle cells. (1997) (215)
- Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. (1987) (197)
- Hyperhomocysteinemia accelerates atherosclerosis in cystathionine beta-synthase and apolipoprotein E double knock-out mice with and without dietary perturbation. (2003) (183)
- Inhibition of platelet function by organic nitrate vasodilators. (1980) (178)
- Adenovirus-Mediated Heme Oxygenase-1 Gene Delivery Inhibits Injury-Induced Vascular Neointima Formation (2001) (178)
- The prethrombotic state in cancer. (1990) (176)
- Hyperhomocysteinemia Decreases Circulating High-Density Lipoprotein by Inhibiting Apolipoprotein A-I Protein Synthesis and Enhancing HDL Cholesterol Clearance (2006) (176)
- Carbon monoxide inhibits apoptosis in vascular smooth muscle cells. (2002) (174)
- Identification of platelet receptors for prostaglandin I2 and D2. (1979) (173)
- Uremic bleeding: pathogenesis and therapy. (1998) (173)
- Antiplatelet therapy. (1996) (165)
- Heme oxygenase-1-derived carbon monoxide is an autocrine inhibitor of vascular smooth muscle cell growth. (2002) (162)
- Molecular basis of the diagnosis and treatment of polycythemia vera and essential thrombocythemia. (2006) (153)
- Plasmin inhibition of platelet function and of arachidonic acid metabolism. (1985) (153)
- Regulation of homocysteine metabolism and methylation in human and mouse tissues (2010) (153)
- Hyperhomocystinemia Impairs Endothelial Function and eNOS Activity via PKC Activation (2005) (150)
- Effects of nonsteroidal anti-inflammatory therapy on platelets. (1999) (148)
- Effects of recombinant human granulocyte and macrophage colony-stimulating factors on signal transduction pathways in human granulocytes. (1987) (146)
- Hemodialysis-associated platelet activation and thrombocytopenia. (1985) (146)
- Heme oxygenase-1 attenuates vascular remodeling following balloon injury in rat carotid arteries. (2001) (142)
- In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs. (2015) (139)
- Homocysteine inhibits endothelial cell growth via DNA hypomethylation of the cyclin A gene. (2007) (138)
- Paraneoplastic thrombocytosis: the secrets of tumor self-promotion. (2014) (130)
- Unidirectional transfer of prostaglandin endoperoxides between platelets and endothelial cells. (1984) (127)
- Platelet protein phosphorylation, elevation of cytosolic calcium, and inositol phospholipid breakdown in platelet activation induced by plasmin. (1986) (126)
- Hyperhomocysteinemia Promotes Inflammatory Monocyte Generation and Accelerates Atherosclerosis in Transgenic Cystathionine &bgr;-Synthase–Deficient Mice (2009) (125)
- In vivo two-photon excited fluorescence microscopy reveals cardiac- and respiration-dependent pulsatile blood flow in cortical blood vessels in mice. (2012) (124)
- The role of platelets in thrombotic and vascular disease. (1979) (122)
- Transforming Growth Factor-β1 Stimulates l-Arginine Transport and Metabolism in Vascular Smooth Muscle Cells (2001) (122)
- Physiological cyclic stretch causes cell cycle arrest in cultured vascular smooth muscle cells. (2000) (120)
- Deficiency of platelet lipoxygenase activity in myeloproliferative disorders. (1982) (120)
- Hemin Upregulates Egr-1 Expression in Vascular Smooth Muscle Cells via Reactive Oxygen Species ERK-1/2–Elk-1 and NF-&kgr;B (2008) (118)
- Carbon monoxide and vascular cell function (review). (1998) (109)
- Protein kinase C is activated in platelets subjected to pathological shear stress. (1993) (107)
- Endoplasmic Reticulum Stress Stimulates Heme Oxygenase-1 Gene Expression in Vascular Smooth Muscle (2005) (97)
- Shear-induced platelet aggregation is inhibited by in vivo infusion of an anti-glycoprotein IIb/IIIa antibody fragment, c7E3 Fab, in patients undergoing coronary angioplasty. (1995) (94)
- Effects on platelet aggregation and fibrinolytic activity during upright posture and exercise in healthy men. (1992) (94)
- Hypercoagulable states: molecular genetics to clinical practice (1994) (92)
- The induction of nitric oxide synthase activity is inhibited by TGF-β1, PDGFAB and PDGFBB in vascular smooth muscle cells (1992) (92)
- The vanishing physician-scientist? (2010) (90)
- Physiological cyclic stretch directs L‐arginine transport and metabolism to collagen synthesis in vascular smooth muscle (2000) (89)
- Comparative real-time effects on platelet adhesion and aggregation under flowing conditions of in vivo aspirin, heparin, and monoclonal antibody fragment against glycoprotein IIb-IIIa. (1995) (88)
- Physiologic cyclic stretch inhibits apoptosis in vascular endothelium (2003) (86)
- IL-1 and related cytokines enhance thrombin-stimulated PGI2 production in cultured endothelial cells without affecting thrombin-stimulated von Willebrand factor secretion or platelet-activating factor biosynthesis. (1989) (82)
- cAMP induces heme oxygenase-1 gene expression and carbon monoxide production in vascular smooth muscle. (1997) (81)
- Platelet-derived Growth Factor Regulates Vascular Smooth Muscle Cell Proliferation by Inducing Cationic Amino Acid Transporter Gene Expression (*) (1996) (80)
- Therapy of chronic relapsing thrombotic thrombocytopenic purpura with prednisone and azathioprine (1985) (79)
- Platelet‐derived growth factor stimulates LAT1 gene expression in vascular smooth muscle: Role in cell growth (2004) (78)
- Arachidonic acid stimulates mucin secretion in prairie dog gallbladder. (1983) (77)
- Hemostatic complications in young patients with essential thrombocythemia. (1990) (77)
- Hyperhomocysteinemia impairs endothelium-derived hyperpolarizing factor-mediated vasorelaxation in transgenic cystathionine beta synthase-deficient mice. (2011) (76)
- Endothelial cell adenylate cyclase: activation by catecholamines and prostaglandin I2+. (1980) (74)
- Platelet-derived growth factor stimulates heme oxygenase-1 gene expression and carbon monoxide production in vascular smooth muscle cells. (1999) (73)
- Thrombocytosis and thrombocythemia. (2001) (72)
- Second messenger function of phosphatidic acid in platelet activation (1989) (72)
- Platelet resistance to prostaglandin D2 in patients with myeloproliferative disorders (1978) (71)
- Thrombotic disorders: diagnosis and treatment. (2003) (70)
- PGE1 accelerates thrombolysis by tissue plasminogen activator. (1989) (67)
- Differential regulation of L-arginine transport and nitric oxide production by vascular smooth muscle and endothelium. (1996) (65)
- Transforming growth factor-beta(1) stimulates L-arginine transport and metabolism in vascular smooth muscle cells: role in polyamine and collagen synthesis. (2001) (65)
- Cyclin A transcriptional suppression is the major mechanism mediating homocysteine-induced endothelial cell growth inhibition. (2002) (62)
- A perspective on the potential problems with aspirin as an antithrombotic agent: a comparison of studies in an animal model with clinical trials. (1999) (61)
- YC-1-mediated vascular protection through inhibition of smooth muscle cell proliferation and platelet function. (2002) (61)
- Vascular lipoxygenase activity: synthesis of 15-hydroxyeicosatetraenoic acid from arachidonic acid by blood vessels and cultured vascular endothelial cells. (1987) (59)
- Endothelium-derived relaxing factor inhibits thrombin-induced platelet aggregation by inhibiting platelet phospholipase C. (1992) (58)
- Teratogenic effects of antileukemic chemotherapy. (1981) (57)
- Differential regulation of L-arginine transport and inducible NOS in cultured vascular smooth muscle cells. (1995) (56)
- Antiapoptotic Action of Carbon Monoxide on Cultured Vascular Smooth Muscle Cells (2003) (54)
- Lysophosphatidylcholine Regulates Cationic Amino Acid Transport and Metabolism in Vascular Smooth Muscle Cells (1997) (53)
- The influence of chemotherapy on response of patients with hematologic malignancies to influenza vaccine (1979) (52)
- Low-molecular-weight heparin--an opportunity for home treatment of venous thrombosis. (1996) (51)
- YC-1, a benzyl indazole derivative, stimulates vascular cGMP and inhibits neointima formation. (2000) (50)
- Effect of alternate-day regular and enteric-coated aspirin on platelet aggregation, bleeding time, and thromboxane A2 levels in bleeding-time blood. (1986) (47)
- Thrombin stimulates vascular smooth muscle cell polyamine synthesis by inducing cationic amino acid transporter and ornithine decarboxylase gene expression. (1998) (46)
- Plasmin potentiates induction of nitric oxide synthesis by interleukin-1 beta in vascular smooth muscle cells. (1993) (46)
- Effects of low-dose aspirin on in vitro platelet aggregation in the early minutes after ingestion in normal subjects. (1994) (42)
- Prostacyclin and beta-adrenergic catecholamines inhibit arachidonate release and PGI2 synthesis by vascular endothelium (1981) (41)
- Ethanol potentiates interleukin-1 beta-stimulated inducible nitric oxide synthase expression in cultured vascular smooth muscle cells. (1995) (40)
- Heterogeneity of heparin lots associated with thrombocytopenia and thromboembolism. (1984) (39)
- Differential Regulation of Homocysteine Transport in Vascular Endothelial and Smooth Muscle Cells (2007) (38)
- Synergistic inhibition of platelet activation by plasmin and prostaglandin I2. (1987) (38)
- Venous thrombosis as a chronic disease. (1999) (37)
- Stalled cerebral capillary blood flow in mouse models of essential thrombocythemia and polycythemia vera revealed by in vivo two‐photon imaging (2014) (36)
- Synthesis of a new series of potent inhibitors of thromboxane A2 biosynthesis (1983) (36)
- Fibrinolysis inhibits shear stress-induced platelet aggregation. (1995) (34)
- Genetic and acquired determinants of individual variability of response to antiplatelet drugs. (2003) (33)
- Long-term efficacy of deferoxamine iron chelation therapy in adults with acquired transfusional iron overload. (1985) (32)
- Thrombocytosis and thrombocythemia. (1990) (32)
- Cure of hemophilia A by orthotopic liver transplantation. (1988) (30)
- Microvascular disturbances, thrombosis, and bleeding in thrombocythemia: current concepts and perspectives. (1997) (30)
- Local administration of carbon monoxide inhibits neointima formation in balloon injured rat carotid arteries. (2005) (30)
- Enhancement of thrombin‐ and lonomycin‐stimulated prostacyclin and platelet‐activating factor production in cultured endothelial cells by a tumor‐promoting phorbol ester (1990) (28)
- Turnover of eicosanoid precursor fatty acids among phospholipid classes and subclasses of cultured human umbilical vein endothelial cells. (1989) (28)
- Nonatheromatous arterial thrombosis. (1993) (27)
- Incorporation of platelet and leukocyte lipoxygenase metabolites by cultured vascular cells (1986) (26)
- Epinephrine and shear stress synergistically induce platelet aggregation via a mechanism that partially bypasses VWF-GP IB interactions. (1996) (26)
- Antithrombotic therapy in patients with acute coronary syndromes. (2001) (26)
- The Analysis of Ligand-Receptor Interactions in Platelet Activation (1995) (25)
- Association of IgA Multiple Myeloma with Pre‐existing Disease (1979) (24)
- Control of platelet protein kinase C activation by cyclic AMP. (1988) (24)
- The pathobiology of thrombosis, microvascular disease, and hemorrhage in the myeloproliferative neoplasms. (2021) (24)
- Desensitization of prostaglandin-activated platelet adenylate cyclase. (1979) (24)
- Platelet alpha 2 adrenoceptor characteristics during the morning increase in platelet aggregability. (1992) (24)
- Platelet inhibition by an L-arginine-derived substance released by IL-1 beta-treated vascular smooth muscle cells. (1991) (23)
- The effect of enteric-coated aspirin on the morning increase in platelet activity. (1991) (22)
- Prostacyclin and beta-adrenergic catecholamines inhibit arachidonate release and PGI2 synthesis by vascular endothelium. (1981) (22)
- Thrombin inhibits induction of nitric oxide synthase in vascular smooth muscle cells. (1993) (21)
- Cyclic nucleotide regulation of interleukin-1 beta induced nitric oxide synthase expression in vascular smooth muscle cells. (1994) (21)
- Inhibition of vascular endothelial cell prostacyclin synthesis by plasmin. (1989) (21)
- Vascular endothelium: in defense of blood fluidity. (1997) (21)
- Transforming growth factor-beta 1 stimulates vascular smooth muscle cell L-proline transport by inducing system A amino acid transporter 2 (SAT2) gene expression. (2001) (21)
- Preferential incorporation of eicosanoid precursor fatty acids into human umbilical vein endothelial cell phospholipids. (1987) (20)
- Platelets inhibit the induction of nitric oxide synthesis by interleukin-1β in vascular smooth muscle cells (1994) (20)
- Severe hemolytic anemia following mitral valve repair. (1989) (20)
- Selective induction of a cationic amino acid transporter by tumor necrosis factor-alpha in vascular endothelium. (1996) (18)
- Monoclonal antibody AG-1 initiates platelet activation by a pathway dependent on glycoprotein IIb-IIIa and extracellular calcium. (1992) (17)
- Comprar Goldman's Cecil Medicine, 24th Edition Expert Consult Premium Edition -- Enhanced Online Features and Print, Two Volume Set | Lee Goldman | 9781437727883 | Saunders (2011) (16)
- Regulation of platelet arachidonic acid oxygenation by cyclic AMP. (1980) (16)
- Platelet interaction with vascular smooth muscle in synthesis of prostacyclin. (1991) (16)
- Platelet lipoxygenase-dependent oxygen burst. Evidence for differential activation of lipoxygenase in intact and disrupted human platelets. (1982) (15)
- Regulation of the phosphoinositide cycle by Na+/H+ exchange and intracellular pH in human platelets. (1991) (15)
- Platelet resistance to prostaglandin D2 in patients with myeloproliferative disorders. (1978) (15)
- Warfarin for venous thromboembolism - walking the dosing tightrope. (2003) (14)
- Monoclonal gammopathy in hereditary spherocytosis: a possible pathogenetic relation. (1978) (14)
- Regulation of interleukin-1-beta-stimulated inducible nitric oxide synthase expression in cultured vascular smooth muscle cells by hemostatic proteins. (1996) (13)
- Focussing of the clot: normal and pathologic mechanisms. (1987) (13)
- Cyclic strain stimulates L-proline transport in vascular smooth muscle cells. (2004) (13)
- Antiplatelet therapy with glycoprotein IIb/IIIa receptor inhibitors and other novel agents. (1997) (13)
- The role of thrombin and thrombin inhibitors in coronary angioplasty. (1995) (12)
- The induction of nitric oxide synthase activity is inhibited by TGF-beta 1, PDGFAB and PDGFBB in vascular smooth muscle cells. (1992) (11)
- Translating basic discoveries into better health care: the APM's recommendations for improving translational research. (2004) (11)
- The Cyclic GMP Modulators YC-1 and Zaprinast Reduce Vessel Remodeling Through Antiproliferative and Proapoptotic Effects (2009) (11)
- Perspective: The Successful Physician-Scientist of the 21st Century (2010) (10)
- Regulation of endothelial cell function by cyclic nucleotides (1984) (10)
- Molecular mechanisms of hypercoagulable states (1997) (10)
- Incremental Utility of Right Ventricular Dysfunction in Patients With Myeloproliferative Neoplasm-Associated Pulmonary Hypertension. (2019) (9)
- Thrombocytosis: When is an incidental finding serious? (2006) (9)
- Incorporation of platelet and leukocyte lipoxygenase metabolites by cultured vascular cells. (1986) (9)
- The Fault Lines of Academic Medicine (2002) (9)
- Streptokinase inhibits acute platelet thrombus formation in stenosed dog coronary arteries. (1991) (8)
- Crafting an effective strategic plan for a department of medicine. (2005) (8)
- Thrombocytosis: too much of a good thing? (2002) (7)
- current concepts Thrombocytosis (2004) (7)
- Management of thrombocythemia (1996) (7)
- Approach to Medicine, the Patient, and the Medical Profession (2012) (7)
- Deployment of academic subspecialists in the emerging era of primary care. (1995) (7)
- 1 – Approach to Medicine, the Patient, and the Medical Profession: Medicine as a Learned and Humane Profession (2012) (7)
- Endothelium-derived Relaxing Factor Inhibits Shear Stress-induced Platelet Aggregation. (1993) (6)
- Interferon in Polycythemia Vera (PV) Yields Improved Myelofibrosis-Free and Overall Survival (2019) (6)
- 174 – Approach to the Patient with Bleeding and Thrombosis (2012) (6)
- Comprar Goldman's Cecil Medicine, 24th Edition Expert Consult Premium Edition -- Enhanced Online Features and Print, Single Volume | Andrew I. Schafer | 9781437716047 | Saunders (2011) (6)
- Thrombotic, Vascular, and Bleeding Complications of the Myeloproliferative Neoplasms. (2021) (5)
- Overview of Hemostasis and Fibrinolysis (2002) (5)
- Platelets inhibit the induction of nitric oxide synthesis by interleukin-1 beta in vascular smooth muscle cells. (1994) (5)
- Hairy cell leukemia: diagnosis and management. (1978) (5)
- 179 – Thrombotic Disorders: Hypercoagulable States (2012) (4)
- Antiplatelet effects of fibrinolytic agents: a potential contributor to the hemostatic defect after thrombolysis. (1995) (4)
- 4. Translational Research and the Physician-Scientist (2016) (4)
- Inhibition of plasminogen activator inhibitor-1 expression in vascular smooth muscle cells by protoporphyrins through a heme oxygenase-independent mechanism (2008) (4)
- Comprar Goldman-Cecil Medicine, 2-Volume Set, 25th Edition | Andrew I. Schafer | 9781455750177 | Elsevier Internacional (2015) (4)
- Acquired platelet storage pool deficiency due to severe valvular disease corrected by prosthetic valve replacement (1994) (4)
- Low-molecular-weight heparin for venous thromboembolism. (1997) (4)
- 1. History of the Physician as Scientist (2016) (3)
- The research community now and in the future: APM's recommendations for NIH priorities. (2003) (3)
- Nitric oxide-independent regulation of the vascular injury response (2005) (3)
- Transforming Growth Factor- b 1 Stimulates L -Arginine Transport and Metabolism in Vascular Smooth Muscle Cells Role in Polyamine and Collagen Synthesis (2001) (3)
- Nitric oxide induces heme oxygenase-1 expression in vascular smooth muscle cells (1996) (2)
- Current Education of Physicians: Lost in Translation? (2019) (2)
- Synergistic Inhibition of Platelet Activation by Plasmin and Prostaglandin 12 1504 Blood (2005) (2)
- Case 45-1985: A 56-Year-Old Man with Chronic Liver Disease and Diabetes Mellitus (1985) (2)
- My doctor recently recommended that I take low-dose aspirin to minimize the risk of a heart attack or stroke. I routinely take ibuprofen for arthritis pain. Do I need both, and is it safe to combine the two? (2000) (2)
- Incidence of Infections and Second Cancers in Philadelphia Chromosome-Negative Patients with Myeloproliferative Neoplasms Treated with Ruxolitinib (2017) (1)
- Book ReviewLeavell and Thorup's Fundamentals of Clinical Hematology (1987) (1)
- Thrombosis and hemorrage (1998) (1)
- Bleeding disorders. Finding the cause. (1984) (1)
- 178 – Hemorrhagic Disorders: Disseminated Intravascular Coagulation, Liver Failure, and Vitamin K Deficiency (2012) (1)
- Blood Platelet Function and Medicinal Chemistry (1985) (1)
- 14. Revitalizing the Nation’s Physician-Scientist Workforce: The Association of Professors of Medicine Initiative (2016) (1)
- Optimizing initial therapy of acute venous thromboembolism (2003) (1)
- Physiological cyclic stretch inhibits vascular smooth muscle proliferation (1999) (0)
- 9. The Relationship between Physicians and PhD Scientists in Medical Research (2016) (0)
- Recombinant Interferon-α Reduces Thrombotic Events in Patients with Polycythemia Vera (2019) (0)
- Essential thrombocythemia. (1991) (0)
- 8. The Role of Academic Medical Centers and Medical Schools in the Training and Support of Physician-Scientists (2016) (0)
- Regulation of Homocysteine Transport in Vascular Cells. (2006) (0)
- In Vivo Imaging of Cerebral Circulation In Mouse Models of Polycythemia Vera (2010) (0)
- Genetic Polymorphisms in Arterial Thrombosis and Vascular Disease (2001) (0)
- Vascular Smooth Muscle Cells : Role in Polyamine and Collagen Synthesis Stimulates l-Arginine Transport and Metabolism in 1 β Transforming Growth Factor (2001) (0)
- 7. Engaging Undergraduate Students in Research: Sustaining Our Nation’s Pipeline of Future Biomedical Investigators (2016) (0)
- arbon monoxide inhibits apoptosis in vascular smooth muscle cells (2002) (0)
- IDIOPATHIC HYPEREOSINOPHILIC SYNDROME AS A CAUSE OF MYOCARDITIS (2015) (0)
- C arbon monoxide inhibits apoptosis in vascular smooth muscle cells (2002) (0)
- Jim Interview (2008) (0)
- Transforming Growth Factor-&bgr;1 Stimulates l-Arginine Transport and Metabolism in Vascular Smooth Muscle Cells: Role in Polyamine and Collagen Synthesis (2001) (0)
- Ruxolitinib Can Lead to Weight Gain in Patients with Myeloproliferative Neoplasms By Uncoupling Feeding from Central Leptin Signaling Via JAK2/STAT3 (2018) (0)
- Transforming growth factor-β 1 stimulates vascular smooth muscle cell L-proline transport by inducing system A amino acid transporter 2 ( SAT 2 ) gene expression (0)
- 6. Generation X and the Millennials in Academic Medicine: Developing the Next Generation of Physician-Scientists (2016) (0)
- 15 A Half Century of Clinical Research (2016) (0)
- 13. Restoring and Invigorating an “Endangered Species”: Initiatives by the Association of American Medical Colleges (2016) (0)
- 11. Mentoring the Physician-Scientist: A Developmental Approach (2016) (0)
- Symposium on Recent Advances in Disorders of Bleeding and Thrombosis: Introduction (1998) (0)
- COMINGS AND GOINGS (1984) (0)
- Genetic polymorphisms in arterial thrombosis and vascular disease. (2001) (0)
- B κ Elk-1 and NF-− Oxygen Species ERK-1 / 2 Hemin Upregulates Egr-1 Expression in Vascular Smooth Muscle Cells via Reactive (2007) (0)
- PRESIDENT'S ADDRESS FROM BUDAPEST TO VIENNA AND BACK. (2018) (0)
- Homocysteine Inhibits Cyclin A Promoter Methylation Via DNMT3 Inactivation in Human Endothelial Cells. (2006) (0)
- EPILOGUE. Looking Forward (2016) (0)
- Abstract 16023: Hyperhomocysteinemia Aggravated Hyperglycemia-Induced Endothelial Dysfunction: Role of Calpain (2012) (0)
- 3. The Ecology of Physician-Scientists in Academic Medicine (2016) (0)
- The academic job offer: what to expect and how to negotiate. (2009) (0)
- Abstract 5813: Hyperhomocysteinemia Enhances Bone Marrow-derived and Vessel Resident Ly6C Inflammatory Monocyte Differentiation Contributing to Atherogenesis (2009) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Andrew I. Schafer?
Andrew I. Schafer is affiliated with the following schools: